The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)

被引：0
作者：
Ko, Jenny J.
Xie, Wanling
Heng, Daniel Yick Chin
Kroeger, Nils
Lee, Jae-Lyun
Rini, Brian I.
Knox, Jennifer J.
Bjarnason, Georg A.
Harshman, Lauren Christine
Pal, Sumanta Kumar
Yuasa, Takeshi
Smoragiewicz, Martin
Donskov, Frede
Bamias, Aristotelis
Wood, Lori
Ernst, D. Scott
Agarwal, Neeraj
Vaishampayan, Ulka N.
Rha, Sun Young
Choueiri, Toni K.
机构：
[1] Tom Baker Canc Clin, Calgary, AB, Canada
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Med Greifswald, Dept Urol, Greifswald, Germany
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[9] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[10] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[11] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan
[12] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[13] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[14] Alexandra Peripheral Gen Hosp, Athens, Greece
[15] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[16] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[17] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[18] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[19] Yonsei Univ, Coll Med, Seoul, South Korea
[20] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.398
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页数：1
相关论文
共 50 条
[21]   First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). [J].
Dudani, Shaan ;
Graham, Jeffrey ;
Wells, Connor ;
Pal, Sumanta K. ;
Dizman, Nazli ;
Donskov, Frede ;
Bjarnason, Georg A. ;
Hansen, Aaron Richard ;
Iafolla, Marco Adelmo James ;
Vaishampayan, Ulka N. ;
Porta, Camillo ;
Beuselinck, Benoit ;
Yan, Flora ;
Wood, Lori ;
Liow, Elizabeth Chien Hern ;
Kollmannsberger, Christian K. ;
Yuasa, Takeshi ;
Zhang, Chiyuan A. ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
[22]   Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) [J].
Dudani, Shaan ;
de Velasco, Guillermo ;
Wells, Connor ;
Gan, Chun Loo ;
Donskov, Frede ;
Porta, Camillo ;
Fraccon, Anna ;
Pasini, Felice ;
Hansen, Aaron Richard ;
Bjarnason, Georg A. ;
Beuselinck, Benoit ;
Pal, Sumanta K. ;
Hotte, Sebastien J. ;
Lalani, Aly-Khan A. ;
Yuasa, Takeshi ;
Kanesvaran, Ravindran ;
Reaume, M. Neil ;
Canil, Christina M. ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[23]   First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [J].
Ruiz-Morales, Jose Manuel ;
Swierkowski, Marcin ;
Wells, J. Connor ;
Fraccon, Anna Paola ;
Pasini, Felice ;
Donskov, Frede ;
Bjarnason, Georg A. ;
Lee, Jae-Lyun ;
Sim, Hao-Wen ;
Sliwczynsk, Andrzej ;
Ptak-Chmielewska, Aneta ;
Teter, Zbigniew ;
Beuselinck, Benoit ;
Wood, Lori A. ;
Yuasa, Takeshi ;
Pezaro, Carmel ;
Rini, Brian I. ;
Szczylik, Cezary ;
Choueiri, Toni K. ;
Heng, Daniel Y. C. .
EUROPEAN JOURNAL OF CANCER, 2016, 65 :102-108
[24]   Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC). [J].
Ernst, Matthew Scott ;
Navani, Vishal ;
Wells, J. Connor ;
Donskov, Frede ;
Basappa, Naveen S. ;
Labaki, Chris ;
Pal, Sumanta K. ;
Meza, Luis A. ;
Wood, Lori ;
Ernst, D. Scott ;
Szabados, Bernadett ;
Mckay, Rana R. ;
Parnis, Francis ;
Suarez, Cristina ;
Yuasa, Takeshi ;
Kapoor, Anil ;
Alva, Ajjai Shivaram ;
Bjarnason, Georg A. ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[25]   A new prognostic model of survival in second-line targeted therapy (TT) for metastatic renal cell carcinoma (mRCC). [J].
Derosa, Lisa ;
Bayar, Mohamed Amine ;
Albiges, Laurence ;
Massard, Christophe ;
Loriot, Yohann ;
Fizazi, Karim ;
Le Teuff, Gwenael ;
Escudier, Bernard J. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[26]   Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings [J].
Tanaka, Nobuyuki ;
Mizuno, Ryuichi ;
Shirotake, Suguru ;
Ito, Keiichi ;
Yasumizu, Yota ;
Masunaga, Ayako ;
Ito, Yujiro ;
Miyazaki, Yasumasa ;
Hagiwara, Masayuki ;
Kanao, Kent ;
Mikami, Shuji ;
Nakagawa, Ken ;
Momma, Tetsuo ;
Masuda, Takeshi ;
Asano, Tomohiko ;
Oyama, Masafumi ;
Oya, Mototsugu .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (07) :293.e17-293.e25
[27]   Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). [J].
Graham, Jeffrey ;
Wells, Connor ;
Donskov, Frede ;
Lee, Jae-Lyun ;
Fraccon, Anna Paola ;
Pasini, Felice ;
Porta, Camillo ;
Bowman, I. Alex ;
Bjarnason, Georg A. ;
Ernst, D. Scott ;
Rha, Sun Young ;
Beuselinck, Benoit ;
Hansen, Aaron Richard ;
North, Scott A. ;
Kollmannsberger, Christian K. ;
Wood, Lori ;
Vaishampayan, Ulka N. ;
Pal, Sumanta K. ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[28]   Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [J].
Laguna, M. Pilar .
JOURNAL OF UROLOGY, 2017, 197 (03) :603-603
[29]   New prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC) [J].
Derosa, L. ;
Guida, A. ;
Albiges, L. ;
Massard, C. ;
Loriot, Y. ;
Galli, L. ;
Fizazi, K. ;
Escudier, B. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 :S478-S479
[30]   New prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC) [J].
Derosa, L. ;
Guida, A. ;
Albiges, L. ;
Massard, C. ;
Loriot, Y. ;
Biasco, E. ;
Farnesi, A. ;
Marconcini, R. ;
Galli, L. ;
Falcone, A. ;
Fizazi, K. ;
Escudier, B. .
ANNALS OF ONCOLOGY, 2015, 26 :53-53
12345